jiangsu lanfeng bio-chemic-a
(002513:Shenzhen)
jiangsu lanfeng bio-chemic-a (002513) Snapshot
|
Open
CNY10.36
|
Previous Close
CNY10.43
|
|
|
Day High
CNY10.55
|
Day Low
CNY10.36
|
|
|
52 Week High
08/24/12 - CNY15.38
|
52 Week Low
12/4/12 - CNY8.07
|
|
|
Market Cap
2.2B
|
Average Volume 10 Days
1.8M
|
|
|
EPS TTM
CNY0.28
|
Shares Outstanding
213.1M
|
|
|
EX-Date
--
|
P/E TM
38.1x
|
|
|
Dividend
CNY0.10
|
Dividend Yield
1.19%
|
Related News
jiangsu lanfeng bio-chemic-a (002513) Related Businessweek News
No Related Businessweek News Foundjiangsu lanfeng bio-chemic-a (002513) Details
Jiangsu Lanfeng Bio-chemical Co.,Ltd. provides agrochemical products in China and internationally. The company offers a range of fungicides, such as propamocarb, thiophanate, carbendazim, prochloraz, diethofencarb, iprodione, and benomyl. It also provides various insecticides, including imidacloprid, pyridaben, acephate, thiodicarb, methomyl, lambda-cyhalothrin, beta-cypermethrin, zeta-cypermethrin, cypermethrin, permethrin, chlorpyrifos-methyl, chlorpyrifos, and acetamiprid. In addition, the company offers herbicide products consisting of mesotrione, dicamba, glyphosate, monolinuron, tebuthiuron, metamitron, chlortoluron, isoproturon, metazachlor, and hexazinone, as well as intermediates related to phosgene. Jiangsu Lanfeng Bio-chemical Co.,Ltd. was founded in 1976 and is based in Xinyi, China.
jiangsu lanfeng bio-chemic-a (002513) Key Developments
Jiangsu Lanfeng Bio-chemical Co.,Ltd. announced that they will report Q1, 2013 results on Apr 20, 2013
Jiangsu Lanfeng Bio-chemical Co.,Ltd. proposed the cash dividend of CNY 1.00000000 per 10 shares (tax included) for 2012.
Jiangsu Lanfeng Bio-chemical Co.,Ltd., Annual General Meeting, Apr 22, 2013., at 14:00 China Standard Time. Agenda: To consider 2012 work report of the board of directors; to consider 2012 work report of the supervisory committee; to consider 2012 annual report and its summary; to consider 2012 financial resolution report; to consider 2012 profit distribution plan; to consider reappointment of audit firm; to consider 2012 internal control self-evaluation report; to consider special report on storage and use of raised funds in 2012; to consider 2013 annual remuneration for directors and senior management; to consider 2013 annual remuneration for supervisors; to consider 2013 continuing connected transactions estimate.
| Recently Viewed | |||
| 002513:CH | CNY10.54 CNY | +0.11 | |
| Company | Last | Change | |
| No competitor information is available for 002513. | |||
| View Industry Companies | |||
Industry Analysis
002513
Industry Average
| Valuation | 002513 | Industry Range |
| Price/Earnings | 47.0x |
|
| Price/Sales | 1.9x |
|
| Price/Book | 2.0x |
|
| Price/Cash Flow | 47.0x |
|
| TEV/Sales | 0.9x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact JIANGSU LANFENG BIO-CHEMIC-A, please visit www.jslanfeng.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








